Octane Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-12-2024
- Paid Up Capital ₹ 0.29 M
as on 24-12-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.30 Cr
as on 24-12-2024
- Satisfied Charges ₹ 3.26 Cr
as on 24-12-2024
- Revenue -26.30%
(FY 2021)
- Profit -17.40%
(FY 2021)
- Ebitda -16.37%
(FY 2021)
- Net Worth 8.15%
(FY 2021)
- Total Assets 2.06%
(FY 2021)
About Octane Biotech
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.29 M.
The company currently has active open charges totaling ₹3.30 Cr. The company has closed loans amounting to ₹3.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjiv Agarwal, Pulkit Agarwal, and Deepa Agarwal serve as directors at the Company.
- CIN/LLPIN
U24232UP2004PTC028667
- Company No.
028667
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Octane Biotech Private Limited offer?
Octane Biotech Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Dry Syrups, Health Conditions, Respiratory Care, Popular Category, Mind Care.
Who are the key members and board of directors at Octane Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjiv Agarwal  | Director | 25-May-2004 | Current |
| Pulkit Agarwal | Director | 15-Jul-2024 | Current |
| Deepa Agarwal | Director | 03-May-2011 | Current |
Financial Performance of Octane Biotech.
Octane Biotech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 26.3% decrease. The company also saw a substantial fall in profitability, with a 17.4% decrease in profit. The company's net worth moved up by a moderate rise of 8.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Octane Biotech?
In 2021, Octane Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ganpati Kamal Developers Private LimitedActive 11 years 9 monthsSanjiv Agarwal and Deepa Agarwal are mutual person
- Octane Hospitality Private LimitedActive 10 years 4 months
Sanjiv Agarwal and Deepa Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Sep 2017 | ₹3.30 Cr | Open |
Others Creation Date: 27 Oct 2017 | ₹1.80 Cr | Satisfied |
Axis Bank Limited Creation Date: 18 Oct 2014 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Octane Biotech?
Octane Biotech has a workforce of 80 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Octane Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Octane Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
